MiMedx Group (MDXG) Tops Q2 EPS by 2c

MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $81.3 million versus the consensus estimate of $74.84 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04